Hospital stocks rallied after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially cutting prices by 20–70% and saving patients ₹2,500 crore annually. Brokerages said earnings effects may be manageable but warned that hospital margins could face pressure.
3 min read9 Oct 2026New guidelines widen monitoring of AI-enabled devices, software glitches and cybersecurity risks while extending reporting to primary health centres.
3 min read9 Oct 2026The Supreme Court’s scrutiny of medicine mark-ups has raised concerns over hospital margins, even as robust demand for tertiary care continues to support the sector.
3 min read2 Oct 2026Stocks, such as Max Healthcare Institute (down 7%), Apollo Hospitals Enterprise (down 6%), Yatharth Hospital (down 5%), Fortis Healthcare (down 6%), Artemis Medicare Services (down 5%), and Aster DM Quality Care (down 5%), crashed 5-7%.
2 min read30 Sep 2026In June 2018, the newly constituted independent Board, with the support of established investment bankers and legal advisors, initiated a competitive bidding process to identify and induct a new investor into the company.
4 min read27 Sep 2026Doctors are pushing for AI to not only improve productivity and diagnosis but also address issues including second opinions, faster test results and quicker access to doctors, freeing up their time to see more patients.
5 min read23 Sep 2026Centre starts consultations with hospitals after Maharashtra FDA Commissioner Tukaram Mundhe's call for a national review of the markup borne by patients.
4 min read19 Sep 2026Mundhe's foray into hospital pricing follows an aggressive run at Mumbai's food sector earlier this year, when his inspections led to the temporary shutdown of several well-known eateries over hygiene violations.
3 min read15 Sep 2026At 93, Dr. Prathap Reddy still runs the healthcare empire he built from a 150-bed Chennai hospital, transforming private healthcare in India and inspiring a new generation to “think bigger”.
3 min read22 Aug 2026The likely deal will be secondary in nature, with existing investor True North looking to sell its over decade-old stake in Cloudnine
4 min read17 Aug 2026Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.